Custom screening strategies for complex muscle organs

This poster is being hosted on this website in its raw form, without modifications. It has not undergone peer review but has been reviewed to meet AZoNetwork's editorial quality standards. The information contained is for informational purposes only and should not be considered validated by independent peer assessment. 

Contracted research

Screening of drug candidates and other compounds on human and animal muscle organs, including 3D human skeletal muscle, iPSC-derived systems, and neuromuscular junction models. We provide a comprehensive assessment of muscle morphology and function, delivering high-quality data on toxicity and efficacy.

Research and development

 Development of bespoke assays to enable drug discovery against specific modalities, including disease, exercise, injury, and rehabilitation.

Custom screening strategies for complex muscle organs

Image Credit: Myomaker Bio

Muscle organs

  • 3D human-derived muscle organs
  • Designed for bespoke preclinical assays
  • Organs are cultured in multi-well plate format

Validation of pharmaceutical agents including:

  • Barium Chloride
  • Leucine
  • d-tubocurarine
  • Insulin
  • Resolvin E1 (RvE1)
  • Testosterone

Organ cell types:

  1. Human: Primary, cell line and iPSC
  2. Animal
    1. Rodent (rat, mice)
    2. Small mammal (rabbit)
    3. Other: Zebra Fish

    Myomaker organ 1: Chemical injury has been modelled using barium chloride, cardiotoxin and tubocurarine. Barium chloride ablates muscle fibres (left), this injury is followed by regeneration.

    Myomaker organ 1: Chemical injury has been modelled using barium chloride, cardiotoxin and tubocurarine. Barium chloride ablates muscle fibres (left), this injury is followed by regeneration. Image Credit: Myomaker Bio

    Neuromuscular organs

    • Skeletal muscle organ with functional neuromuscular junctions
    • Demonstrated by pre- and post synaptic colocalization

    Custom screening strategies for complex muscle organs

    Image Credit: Myomaker Bio

    Myomaker organ 2: Spontaneous twitch in muscle organs with iPSC motor neurons (red) and without (blue)

    Myomaker organ 2: Spontaneous twitch in muscle organs with iPSC motor neurons (red) and without (blue). Inhibition of acetylcholine receptor in spontaneously contracting neuromuscular tissues demonstrated with the addition of d-Tubocurarine. Image Credit: Myomaker Bio

    Model outputs

    1. Morphology (cryosectioning, immunocytochemistry)
    2. Functional analysis (evoked and spontaneous contraction)
    3. Gene and protein expression (inc. RNAseq)
    4. Media analysis (inc. creatine kinase, lactate)

    Custom screening strategies for complex muscle organs

    Image Credit: Myomaker Bio

    Model development

    Muscle organs can be combined with other human cells (including disease modalities) to generate multifunctional organs. Myomaker Bio has extensive experience in the development of novel models for understanding muscle biology.

    Models developed:

    • Mechanical and electrical loading
    • Chemical Injury
    • Shockwave Injury
    • Metabolic Disease

    Myomaker Organ 3: Sensory innervated muscle.

    Myomaker Organ 3: Sensory innervated muscle. Image Credit: Myomaker Bio

    Myomaker Organ 4: Vascularised Muscle.

    Myomaker Organ 4: Vascularised Muscle. Image Credit: Myomaker Bio

    About Myomaker Bio

    Myomaker Bio is a spinout from Loughborough University and a recognized leader in muscle biology. The team brings decades of scientific, managerial, and leadership experience, with deep expertise in muscle organ research. Myomaker Bio provides comprehensive support across all stages of drug discovery and development where muscle testing is required.

    About ELRIG (UK) Ltd.

    The European Laboratory Research & Innovation Group (ELRIG) is a leading European not-for-profit organization that exists to provide outstanding scientific content to the life science community. The foundation of the organization is based on the use and application of automation, robotics and instrumentation in life science laboratories, but over time, we have evolved to respond to the needs of biopharma by developing scientific programmes that focus on cutting-edge research areas that have the potential to revolutionize drug discovery.

    Comprised of a global community of over 12,000 life science professionals, participating in our events, whether it be at one of our scientific conferences or one of our networking meetings, will enable any of our community to exchange information, within disciplines and across academic and biopharmaceutical organizations, on an open access basis, as all our events are free to attend!

    Our values

    Our values are to always ensure the highest quality of content, that content will be made readily accessible to all, and that we will always be an inclusive organization, serving a diverse scientific network. In addition, ELRIG will always be a volunteer-led organization, run by and for the life sciences community, on a not-for-profit basis.

    Our purpose

    ELRIG is a company whose purpose is to bring the life science and drug discovery communities together to learn, share, connect, innovate and collaborate, on an open access basis. We achieve this through the provision of world-class conferences, networking events, webinars, and digital content.


    Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

    Last Updated: Dec 1, 2025

    Citations

    Please use one of the following formats to cite this article in your essay, paper or report:

    • APA

      Myomaker Bio. (2025, December 01). Custom screening strategies for complex muscle organs. News-Medical. Retrieved on December 04, 2025 from https://www.news-medical.net/health/Custom-screening-strategies-for-complex-muscle-organs.aspx.

    • MLA

      Myomaker Bio. "Custom screening strategies for complex muscle organs". News-Medical. 04 December 2025. <https://www.news-medical.net/health/Custom-screening-strategies-for-complex-muscle-organs.aspx>.

    • Chicago

      Myomaker Bio. "Custom screening strategies for complex muscle organs". News-Medical. https://www.news-medical.net/health/Custom-screening-strategies-for-complex-muscle-organs.aspx. (accessed December 04, 2025).

    • Harvard

      Myomaker Bio. 2025. Custom screening strategies for complex muscle organs. News-Medical, viewed 04 December 2025, https://www.news-medical.net/health/Custom-screening-strategies-for-complex-muscle-organs.aspx.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.